Optionale Produktanalyse
Mit Ihrer Erlaubnis verwenden wir datenschutzfreundliche Analysen, um zu verstehen, welche Recherchewege funktionieren. Wir verwenden weder Werbe-Tracker noch Sitzungsaufzeichnungen. Sie können diese Auswahl in den Einstellungen ändern. Lesen Sie die Datenschutzerklärung.
Erie Indemnity Company's published Sell conclusion compares the analysis-date price with fair value and potential value. Read the full report for assumptions, evidence, and material risks.
| Market cap | $12.5B | |
|---|---|---|
| Revenue (ttm) | 4.1B | |
| Net income (ttm) | 577M | |
| EPS (ttm) | $11.0 | |
| Shares out | 52.3M | |
| P/E (trailing) | 22.2x | |
| P/E (forward) | 26.7x | |
| Dividend | $5.85 (2.39%) | |
| Volume | 127,947 | |
| Beta | 0.33 |
Recent price action with selectable time range.
| Item | P1 | P2 | P3 | P4 | P5 | Trend |
|---|---|---|---|---|---|---|
| Period | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | Trend |
| Revenue | $2.63B | $2.84B | $3.27B | $3.80B | $4.07B | +11.5% |
| Gross profit | $2.70B | $376.2M | $520.3M | $676.5M | $640.8M | -30.2% |
| Operating income | $318.1M | $376.2M | $520.3M | $676.5M | $717.2M | +22.5% |
| Net income | $297.9M | $298.6M | $446.1M | $600.3M | $559.3M | +17.1% |
| EPS (diluted) | $5.61 | $6.08 | $8.69 | $11.49 | $12.24 | +21.5% |
| EBITDA | $-286.1M | $428.4M | $600.2M | $766.3M | $787.4M | — |
| R&D | $0 | $0 | $0 | — | — | +10.2% |
| SG&A | $58.3M | $668.3M | $737.1M | $806.3M | $74.1M | +6.2% |
Recent company headlines from major financial publishers.
In the base scenario, management fee revenue grows steadily in line with regional premium expansion while operating margins remain stable. Reinvestment moderates gradually, aligning intrinsic worth with Fair value $151.31 against the share price at analysis $239.05.
In the bull scenario, policyholder expansion into contiguous states accelerates while modern software deployments streamline administrative operations. Capital spending normalizes toward depreciation, releasing free cash flow and supporting Potential value $226.92.
| Ke ↓ / g → | 1.5% | 2.0% | 2.5% | 3.0% | 3.5% |
|---|---|---|---|---|---|
| 5.0% | $188 | $206 | $230 | $267 | $327 |
| 6.0% | $158 | $168 | $180 | $197 | $220 |
| 7.0% | $138 | $144 | $151 | $161 | $172 |
| 8.0% | $123 | $127 | $132 | $138 | $145 |
| 9.0% | $112 | $115 | $118 | $122 | $127 |
Upcoming earnings date and setup when available.
Das Rating, das die veröffentlichte Research-Ausgabe des jeweiligen Monats trug. Ein Rating vergleicht den Kurs zum Analysezeitpunkt mit dem Fair Value; es ist kein Nachweis, ob die Einschätzung zutraf.
| Jahr | Jan | Feb | Mär | Apr | Mai | Jun | Jul | Aug | Sep | Okt | Nov | Dez |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 |